Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Shares Gap Up – Should You Buy?

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $8.60, but opened at $8.87. Shionogi & Co., Ltd. Unsponsored ADR shares last traded at $8.8950, with a volume of 3,060 shares traded.

Shionogi & Co., Ltd. Unsponsored ADR Stock Performance

The stock’s 50-day moving average is $8.47 and its 200-day moving average is $8.59. The company has a current ratio of 6.44, a quick ratio of 5.74 and a debt-to-equity ratio of 0.01. The stock has a market cap of $15.11 billion, a price-to-earnings ratio of 13.88, a P/E/G ratio of 2.10 and a beta of 0.20.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last released its quarterly earnings data on Monday, October 27th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.02. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 39.53% and a return on equity of 11.90%. The company had revenue of $740.85 million during the quarter, compared to the consensus estimate of $742.35 million. On average, analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.